Yang Jun-Quan, Liu Hong-Xia, Liang Zhen, Sun Yu-Man, Wu Meng
Department of Radio-chemotherapy Oncology, Tangshan People's Hospital Tangshan 063001, China.
Department of Pathology, Tangshan Union Hospital Tangshan 063004, China.
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4295-302. eCollection 2014.
The aim of this study was to explore the relationship between the expression of p53, p21 and Cdc2 in the early laryngeal cancer with negative pathological margins and its local recurrence. During 2004-2010, a total of 85 patients with early laryngeal cancer were selected in Tangshan Union Hospital, Hebei, China, and immunohistochemical method was used to detect the expression of p53, p21 and Cdc2 in the negative pathological margin tissues. All patients were followed up for two years to collect pathological data for evaluating the survival and tumor recurrence. Two years after surgery 14 of 85 patients with laryngeal cancer presented with recurrence (recurrent group), while 71 patients without recurrence (none recurrent group). The positive rate of p53, p21 and Cdc2 protein in laryngeal cancer tissues was 60.0% (51/85), 38.8% (33/85) and 70.6% (60/85), respectively, while that of the three proteins in the cancer adjacent tissues was 36.5% (31/85), 21.2% (18/85) and 29.4% (25/85), respectively. The differentiation and TNM stage of tumor had no correlation with the three proteins. The positive rate of p53 in the surgical margin of the recurrent group and non recurrent group was 71.4% (10/14) and 29.6% (21/71) (P = 0.003), that of p21 was 50.0% (7/14) and 15.5% (11/71), (P = 0.011) and Cdc2 was 57.1% (8/14) and 23.9% (17/71) (P = 0.030), respectively. In conclusion, p53, p21 and Cdc2 may be involved in the occurrence, development and recurrence of laryngeal squamous cell carcinoma. Overexpression of p53, p21 and Cdc2 in the surgical margin of early laryngeal cancer is closely related to local recurrence of tumor.
本研究旨在探讨病理切缘阴性的早期喉癌组织中p53、p21和Cdc2的表达与局部复发之间的关系。2004年至2010年期间,在中国河北唐山协和医院选取85例早期喉癌患者,采用免疫组织化学方法检测病理切缘阴性组织中p53、p21和Cdc2的表达。对所有患者进行两年随访,收集病理数据以评估生存情况和肿瘤复发情况。术后两年,85例喉癌患者中有14例出现复发(复发组),71例未复发(未复发组)。喉癌组织中p53、p21和Cdc2蛋白的阳性率分别为60.0%(51/85)、38.8%(33/85)和70.6%(60/85),而癌旁组织中这三种蛋白的阳性率分别为36.5%(31/85)、21.2%(18/85)和29.4%(25/85)。肿瘤的分化程度和TNM分期与这三种蛋白无关。复发组和未复发组手术切缘p53的阳性率分别为71.4%(10/14)和29.6%(21/71)(P = 0.003),p21的阳性率分别为50.0%(7/14)和15.5%(11/71)(P = 0.011),Cdc2的阳性率分别为57.1%(8/14)和23.9%(17/71)(P = 0.030)。综上所述,p53、p21和Cdc2可能参与喉鳞状细胞癌的发生、发展和复发过程。早期喉癌手术切缘中p53、p21和Cdc2的过表达与肿瘤局部复发密切相关。